CN1365828A - Medicine for treating diabetes - Google Patents
Medicine for treating diabetes Download PDFInfo
- Publication number
- CN1365828A CN1365828A CN02103665A CN02103665A CN1365828A CN 1365828 A CN1365828 A CN 1365828A CN 02103665 A CN02103665 A CN 02103665A CN 02103665 A CN02103665 A CN 02103665A CN 1365828 A CN1365828 A CN 1365828A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- medicine
- semen
- colla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A Chinese medicine for treating diabetes and hyperlipomia and preventing thrombosis is prepared from 32 Chinese medicinal materials including ledebouriela root, cimicifuga rhizome, pueraria root, trichosanthes root, bupleurum root, etc.. More than 270 clinic examples show that it has high effective rate (100%).
Description
Invention field
The present invention relates to a kind of medicine for the treatment of diabetes, especially is the Chinese patent medicine of feedstock production with Chinese medicine.
Background technology
At present the treatment diabetes are many with islets of langerhans blood sugar control usually, and this also is present efficient ways.But the function of the beta Cell of islet uelralante of the diabetics that this method does not completely lose two types and islet function produces dependency, and directly influences the recovery of islet function.Other chemicals of life-time service person, hypoglycemic effect is undesirable first, second can not prevent and treat complication, the bonded new product in other Chinese and Western is effective to the mild or moderate diabetics that pancreatic function does not completely lose, and is very poor to juvenile form and severe diabetics curative effect.
Summary of the invention
The objective of the invention is does not only have harm but also can effect a radical cure the new drug of diabetes body in order to provide a kind of, and it can solve the deficiencies in the prior art effectively.
Medicine of the present invention comprises following raw material (weight portion):
Radix Saposhnikoviae 10-20 Rhizoma Cimicifugae 5-15 Radix Puerariae 30-60
Radix Trichosanthis 80-190 Radix Bupleuri 5-15 Radix Glycyrrhizae 10-20
Radix Ginseng 10-20 Rhizoma Zingiberis 5-10 Radix Aconiti Lateralis Preparata 5-10
Semen Coicis 15-45 Radix Scrophulariae 15-25 50-80 Radix Ophiopogonis
Radix Asparagi 50-150 Rhizoma Coptidis 5-25 Cortex Phellodendri 20-75
Rhizoma Atractylodis Macrocephalae 5-25 Colla cornus cervi 5-10 Bulbus Fritillariae Cirrhosae 5-15
Radix Scutellariae 9-20 Fructus Corni 15-45 Radix Rehmanniae 45-105
Radix Paeoniae Alba 8-15 Colla Corii Asini 9-20 Semen Cassiae 25-35
Mirabilitum crystallina 90-160 Talcum 20-35 Rhizoma Anemarrhenae 10-30
Endoconcha Sepiae 15-30 Concha Ostreae 20-35 succinum 10-20
Semen Benincasae 20-35 Gypsum Fibrosum 90-180 Herba Selaginellae 10-30.
The preferred weight proportioning of each component of medicine of the present invention is:
Radix Saposhnikoviae 10-15 Rhizoma Cimicifugae 9-10 Radix Puerariae 30-45
Radix Trichosanthis 90-190 Radix Bupleuri 9-10 Radix Glycyrrhizae 15-20
Radix Ginseng 10-20 Rhizoma Zingiberis 5-10 Radix Aconiti Lateralis Preparata 5-10
Semen Coicis 15-30 Radix Scrophulariae 15-20 50-75 Radix Ophiopogonis
Radix Asparagi 50-150 Rhizoma Coptidis 5-20 Cortex Phellodendri 20-75
Rhizoma Atractylodis Macrocephalae 5-20 Colla cornus cervi 5-10 Bulbus Fritillariae Cirrhosae 5-10
Radix Scutellariae 9-15 Fructus Corni 15-45 Radix Rehmanniae 45-105
Radix Paeoniae Alba 10-15 Colla Corii Asini 9-15 Semen Cassiae 25-35
Mirabilitum crystallina 90-150 Talcum 20-30 Rhizoma Anemarrhenae 10-30
Endoconcha Sepiae 15-30 Concha Ostreae 20-30 succinum 10-15
Semen Benincasae 20-30 cream 90-150 Herba Selaginellae 15-30.
Preparing pharmaceutical methods of the present invention is, described proportion raw material is decocted with water, and makes oral medicine.
The instructions of taking of oral medicine of the present invention is every day 3 times, about each 10-30ml.
Certainly, also can prescription of the present invention be made clinical common dosage forms such as pill, powder, capsule, concentrated pill according to conventional method.
The advantage of medicine of the present invention and good effect:
1, after this medicine enters body, can impel beta Cell of islet regeneration and functional rehabilitation, strengthen secretion of insulin, impel insulin to bring into play its physiological function to greatest extent, thereby improve carbohydrate metabolism better.
2, instant effect, general medication are about 10 days, and it is normal or approaching normal that blood glucose can recover.Sings and symptoms goes down rapidly, regains one's strength, and weight increase, disease resistance enhancemen recovers and keeps normal person's body constitution and life.
3,, can reduce insulin dosage rapidly, up to replacing fully to the insulin dependency diabetes.It can play the effect same with type-II diabetes for a long time.
4, this medical instrument has the reduction hyperlipidemia, prevent arteriosclerosis, the generation of Trombin inhibiting and antithrombotic effect, simultaneously can also keep and recover the normal function of nerve, heart and nitrification, so this medicine has good preventive and therapeutic effect to multiple complications such as diabetic hypertension, diabetic coronary artery disease, diabetic cerebral thrombosiss.
5, this medicine has moistening five ZANG-organs, the effect of supplementing QI and nourishing YIN, and promoting blood circulation, the effect that brute force is healthy and strong, the multiple disease of healthy energy are from going.
Embodiment
Below with non-limiting example the present invention is described.
Radix Saposhnikoviae 15g, Rhizoma Cimicifugae 9g, Radix Puerariae 45g, Radix Trichosanthis 90g, Radix Bupleuri 9g, Radix Glycyrrhizae 15g, Radix Ginseng 15g, Rhizoma Zingiberis 7g, Radix Aconiti Lateralis Preparata 7g, Semen Coicis 30g, Radix Scrophulariae 20g, Radix Asparagi 70g, Radix Ophiopogonis 70g, Rhizoma Coptidis 20g, Cortex Phellodendri 45g, Rhizoma Atractylodis Macrocephalae 20g, Colla cornus cervi 7g, Bulbus Fritillariae Cirrhosae 10g, Radix Scutellariae 15g, Herba Selaginellae 15g, Fructus Corni 20g, Radix Rehmanniae 75g, Radix Paeoniae Alba 10g, Colla Corii Asini 15g, Concha Haliotidis 30g, Mirabilitum crystallina 150g, Talcum 30g, Rhizoma Anemarrhenae 20g, Endoconcha Sepiae 20g, Concha Ostreae 30g, succinum 15g, Semen Benincasae 30g, Gypsum Fibrosum 150g, last 33 flavors are fried in shallow oil 2 times with clear water, the dregs of removing slag merges, and makes oral liquid formulations.
Clinical trial is summed up
With Drug therapy 273 routine diabeticss of the present invention, II type patient 268 examples wherein, I type patient 5 examples.Therapeutic Method is for treating with oral medicine of the present invention, and day clothes 3 times are about each 20-30ml.100% patient is effective as a result, and symptom such as thirsty, frequent micturition, weak etc. has in various degree and take a turn for the better, and blood glucose is reduced.
Claims (3)
1, a kind of medicine for the treatment of diabetes, it comprises the raw material of Chinese medicine that weight proportion is following:
Radix Saposhnikoviae 10-20 Rhizoma Cimicifugae 5-15 Radix Puerariae 30-60
Radix Trichosanthis 80-190 Radix Bupleuri 5-15 Radix Glycyrrhizae 10-20
Radix Ginseng 10-20 Rhizoma Zingiberis 5-10 Radix Aconiti Lateralis Preparata 5-10
Semen Coicis 15-45 Radix Scrophulariae 15-25 50-80 Radix Ophiopogonis
Radix Asparagi 50-150 Rhizoma Coptidis 5-25 Cortex Phellodendri 20-75
Rhizoma Atractylodis Macrocephalae 5-25 Colla cornus cervi 5-10 Bulbus Fritillariae Cirrhosae 5-15
Radix Scutellariae 9-20 Fructus Corni 15-45 Radix Rehmanniae 45-105
Radix Paeoniae Alba 8-15 Colla Corii Asini 9-20 Semen Cassiae 25-35
Mirabilitum crystallina 90-160 Talcum 20-35 Rhizoma Anemarrhenae 10-30
Endoconcha Sepiae 15-30 Concha Ostreae 20-35 succinum 10-20
Semen Benincasae 20-35 cream 90-180 Herba Selaginellae 10-30.
2, according to the medicine of claim 1, wherein each proportion of raw materials is:
Radix Saposhnikoviae 10-15 Rhizoma Cimicifugae 9-10 Radix Puerariae 30-45
Radix Trichosanthis 90-190 Radix Bupleuri 9-10 Radix Glycyrrhizae 15-20
Radix Ginseng 10-20 Rhizoma Zingiberis 5-10 Radix Aconiti Lateralis Preparata 5-10
Semen Coicis 15-30 Radix Scrophulariae 15-20 50-75 Radix Ophiopogonis
Radix Asparagi 50-150 Rhizoma Coptidis 5-20 Cortex Phellodendri 20-75
Rhizoma Atractylodis Macrocephalae 5-20 Colla cornus cervi 5-10 Bulbus Fritillariae Cirrhosae 5-10
Radix Scutellariae 9-15 Fructus Corni 15-45 Radix Rehmanniae 45-105
Radix Paeoniae Alba 10-15 Colla Corii Asini 9-15 Concha Haliotidis 25-35
Mirabilitum crystallina 90-150 Talcum 20-30 Rhizoma Anemarrhenae 10-30
Endoconcha Sepiae 15-30 Concha Ostreae 20-30 succinum 10-15
Semen Benincasae 20-30 cream 90-150 Herba Selaginellae 15-30.
3, prepare the method for the medicine of claim 1 or 2, comprise described raw material is made oral liquid formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021036659A CN1241634C (en) | 2002-02-04 | 2002-02-04 | Medicine for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021036659A CN1241634C (en) | 2002-02-04 | 2002-02-04 | Medicine for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1365828A true CN1365828A (en) | 2002-08-28 |
| CN1241634C CN1241634C (en) | 2006-02-15 |
Family
ID=4739853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021036659A Expired - Fee Related CN1241634C (en) | 2002-02-04 | 2002-02-04 | Medicine for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1241634C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1331514C (en) * | 2005-11-11 | 2007-08-15 | 李永红 | Capsnle for treating type II diabetes |
| WO2009149585A1 (en) * | 2008-06-12 | 2009-12-17 | Sicheng Chen | Compositions for reducing blood glucose level and uses thereof |
| CN101361768B (en) * | 2008-08-23 | 2010-12-22 | 史鹏志 | Diabetes treating medicine |
| CN102552533A (en) * | 2012-02-15 | 2012-07-11 | 梁艳龙 | Chinese medicinal formula for treating diabetes |
| CN102727783A (en) * | 2012-07-23 | 2012-10-17 | 太仓市伟基生物科技有限公司 | Traditional Chinese medicine for preventing and treating diabetes by traditional Chinese medicine lavipeditum and preparation method of traditional Chinese medicine |
-
2002
- 2002-02-04 CN CNB021036659A patent/CN1241634C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1331514C (en) * | 2005-11-11 | 2007-08-15 | 李永红 | Capsnle for treating type II diabetes |
| WO2009149585A1 (en) * | 2008-06-12 | 2009-12-17 | Sicheng Chen | Compositions for reducing blood glucose level and uses thereof |
| US20110104290A1 (en) * | 2008-06-12 | 2011-05-05 | Sicheng Chen | Compositions for reducing blood glucose level and uses thereof |
| JP2011522844A (en) * | 2008-06-12 | 2011-08-04 | チェン スチョン | Composition for reducing blood glucose level and use thereof |
| CN101361768B (en) * | 2008-08-23 | 2010-12-22 | 史鹏志 | Diabetes treating medicine |
| CN102552533A (en) * | 2012-02-15 | 2012-07-11 | 梁艳龙 | Chinese medicinal formula for treating diabetes |
| CN102552533B (en) * | 2012-02-15 | 2014-05-07 | 梁艳龙 | Chinese medicinal formula for treating diabetes |
| CN102727783A (en) * | 2012-07-23 | 2012-10-17 | 太仓市伟基生物科技有限公司 | Traditional Chinese medicine for preventing and treating diabetes by traditional Chinese medicine lavipeditum and preparation method of traditional Chinese medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1241634C (en) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1305844A (en) | Medicine for treating congestive heart failure | |
| CN1122522C (en) | Medicine 'Yishenjieyu' for treating mental diseases (psychosis) | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| CN1053375C (en) | Chinese medicine preparation for hepatosis | |
| CN1205974C (en) | Thirty-six ingredients capsule for treating diabetes | |
| CN1241634C (en) | Medicine for treating diabetes | |
| CN1970021A (en) | Chinese medicine for treating gout and preparation method thereof | |
| CN1111522A (en) | Compound islets Langerhans regenerated capsule | |
| CN100444870C (en) | Medication composition for treating cardiovascular diseases and cerebrovascular disease, and preparation method | |
| CN101049438A (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN1329067C (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN1241623C (en) | Capsule 'Yibao Yishou' for elongating life | |
| CN1230190C (en) | Medicine for treating diabetes | |
| CN1202847C (en) | Diabetes treating medicine | |
| CN1141138C (en) | Medicine composition for curing coronary heart disease | |
| CN1127344C (en) | Oral pill for curing diabetes and its complication | |
| CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
| CN1211426A (en) | Medicine for treating diabetes | |
| CN1060087C (en) | Traditional Chinese medicine extract tablet and preparation method therefor | |
| CN1194733C (en) | Medicine for treating hyperthyroidism and its prepn | |
| CN1055217C (en) | Zengzhiling capsule for intelligence development and its production | |
| CN1057465C (en) | Medicine for treating chronic kidney disease and its prepn. method | |
| CN1101213C (en) | Diabetes treating medicine | |
| CN1186036C (en) | Diabetes treating medicine and its prepn | |
| CN1739663A (en) | Application of ciliate bugle herb piece in preparing medicine for treating scapulohumeral periarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060215 |